Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Expected To Reach $1.29 Billion By 2030 With 18.6% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Grow Between 2026 And 2030?
The topical drugs contract development and manufacturing organization (CDMO) market has seen substantial growth in recent years. It is forecast to increase from $61.16 billion in 2025 to $70.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.0%. This past expansion is attributable to increased pharmaceutical outsourcing, the rising incidence of dermatological conditions, pharmaceutical companies’ efforts in cost optimization, escalating regulatory complexity, and the proliferation of generic topical drugs.
The market for topical drugs contract development and manufacturing organizations (CDMOs) is projected to experience swift expansion over the coming years. This market is anticipated to reach $121.22 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.3%. Key drivers for this growth during the projected period include the escalating development of sophisticated topical treatments, a heightened demand for transdermal patches, the enlargement of small and mid-sized pharmaceutical pipelines, a rising requirement for adaptable manufacturing capabilities, and an intensified emphasis on accelerating market entry. Prominent trends expected within this forecast period encompass an uptick in the outsourcing of topical drug production, an increasing appetite for intricate topical formulations, the broadening of transdermal drug delivery systems, a stronger commitment to manufacturing that adheres to regulations, and a greater call for comprehensive CDMO offerings.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15942&type=smp
What Primary Drivers Are Shaping The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
The rising occurrence of skin diseases is projected to drive the growth of the topical drugs contract development and manufacturing organization (CDMO) market. Skin diseases are defined as medical conditions affecting the skin, leading to symptoms such as inflammation, itching, and lesions. This increasing prevalence is attributed to factors like environmental pollution, UV radiation exposure, genetic predisposition, lifestyle changes, and microbial infections. Topical drugs contract development and manufacturing organization (CDMO) contributes to reducing skin disease prevalence by developing and manufacturing targeted therapies that improve the management and treatment of dermatological conditions. For instance, in 2023, Cancer Australia, an Australia-based government agency, reported approximately 8,257 new cases of melanoma of the skin, which accounted for 2.6% of all deaths from cancer. Thus, the growing prevalence of skin diseases is a key factor propelling the expansion of the topical drugs contract development and manufacturing organization (CDMO) market.
What Are The Main Segments Within The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segment Structure?
The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses
Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders
4) By Transdermal Products: Patches
What Trends Are Shaping The Future Of The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Leading entities within the topical drugs contract development and manufacturing organization (CDMO) market prioritize the establishment of advanced manufacturing facilities to maintain their market standing. Such a facility represents a specialized production site, incorporating cutting-edge technology and sophisticated processes specifically designed for the creation and production of topical pharmaceutical items. An example is SOHM Inc., a US-based pharmaceutical firm, which inaugurated a CDMO GMP manufacturing facility in November 2023. This new Carlsbad facility is designed to provide substantial space for the production of topical products and SOHM’s activities, including 2,500 square feet allocated for the storage of completed goods. Initially, its daily production capability for topicals will be 500 gallons (1,892 liters). Plans anticipate an expansion of its capacity to encompass soft-gel suppositories by the close of Q1 2024 or the commencement of Q2 2024.
Who Are The Companies Participating In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the topical drugs contract development and manufacturing organization (cdmo) market are Catalent Inc., Lonza Group AG, Recipharm AB, Piramal Pharma Solutions, Cambrex Corporation, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., MedPharm Ltd, Tergus Pharma LLC, NextPharma Technologies Holding Limited, Bora Pharmaceuticals Co. Ltd., LTS Lohmann Therapie-Systeme AG, CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., Dow Development Laboratories LLC, Tedor Pharma Inc.
Get The Full Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report:
Which Region Leads The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In Terms Of Market Share?
Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the topical drugs contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market 2026, By The Business Research Company
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
